| Gemcitabine and Bendamustine in Patients With Relapsed or Refractory Hodgkin's Lymphoma (NCT01535924) | Beth Christian | 2012-02-09 |
| Pilot Immunotherapy Trial for Recurrent Malignant Gliomas (NCT01550523) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2012-02-09 |
| Nivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016) (NCT01472081) | Bristol-Myers Squibb | 2012-02-09 |
| Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell (NCT01660607) | Stanford University | 2012-02-09 |
| Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine (NCT01519011) | Celgene | 2012-02-07 |
| A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas (NCT01512758) | Millennium Pharmaceuticals, Inc. | 2012-02-06 |
| Vemurafenib With Sorafenib Tosylate or Crizotinib in Treating Patients With Advanced Malignancies With BRAF Mutations (NCT01531361) | M.D. Anderson Cancer Center | 2012-02-06 |
| Multicenter Study of HGT-1110 Administered Intrathecally in Children With Metachromatic Leukodystrophy (MLD) (NCT01510028) | Shire | 2012-02-02 |
| A Phase 1, Open-Label, Single-photon Emission Computed Tomography (SPECT) Study to Evaluate Serotonin and Dopamine Transporter Occupancy After Multiple Dose Administration of SEP-228432 to Achieve Steady State in Healthy Subjects (NCT01531972) | Sumitomo Pharma America, Inc. | 2012-02-01 |
| Ganitumab and Gemcitabine Hydrochloride Followed by Radiation Therapy, Ganitumab, Capecitabine, and Maintenance Therapy in Treating Patients With Locally Advanced Cancer of the Pancreas (NCT01298401) | Radiation Therapy Oncology Group | 2012-02-01 |
| Treatment of Port-wine Mark in Sturge-Weber Syndrome Using Topical Timolol (NCT01533376) | Wills Eye | 2012-02-01 |
| Endoscopic Myotomy for the Treatment of Achalasia (Motility Disorder) of the Esophagus - POEM Procedure (NCT01873300) | Massachusetts General Hospital | 2012-02-01 |
| Pharmacokinetic Profile of Two Formulations of PB1023 Following Single Subcutaneous Injection in Subjects With Type 2 Diabetes Mellitus (NCT01427257) | PhaseBio Pharmaceuticals Inc. | 2012-02-01 |
| A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Prednisone in Healthy Adult Subjects (NCT01711827) | Astellas Pharma Global Development, Inc. | 2012-02-01 |
| Pilot Study of Gleevec/Imatinib Mesylate (STI-571, NSC 716051) in Neurofibromatosis (NF1) Patient With Plexiform Neurofibromas (NCT01140360) | Kent Robertson | 2012-02-01 |
| Open-label PK Study of Iron Isomaltoside 1000 (Monofer) Administered by 500 mg IV Injection or 1000 mg IV Infusion to Patients With Inflammatory Bowel Disease (NCT01213680) | Pharmacosmos A/S | 2012-02-01 |
| Phase 1 Safety, Tolerability and PK Study of Ondansetron and Hylenex Recombinant in Healthy Volunteers (NCT01572012) | Halozyme Therapeutics | 2012-02-01 |
| Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma (NCT01534585) | Taizhou Hospital | 2012-02-01 |
| Oral QLT091001 in Retinitis Pigmentosa (RP) Subjects With an Autosomal Dominant Mutation in Retinal Pigment Epithelial 65 Protein (RPE65) (NCT01543906) | QLT Inc. | 2012-02-01 |
| A Phase Ib Study of Stereotactic Body Radiotherapy (SBRT) Plus Sorafenib in Patients With Unresectable Hepatocellular Carcinoma (HCC) (NCT01801163) | Indiana University | 2012-02-01 |
| Tadalafil and Nesiritide as Therapy in Pre-clinical Heart Failure (NCT01544998) | Mayo Clinic | 2012-02-01 |
| Study to Evaluate the Safety, Tolerability and the Effect of BMS-241027 on Cerebrospinal Fluid Biomarkers in Subjects With Mild Alzheimer's Disease (NCT01492374) | Bristol-Myers Squibb | 2012-02-01 |
| Single Cohort, 2-Period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine 500 mg (NCT01546558) | Gilead Sciences | 2012-02-01 |
| Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus (NCT01603121) | Eastern Virginia Medical School | 2012-02-01 |
| Tolerability and Safety of Subcutaneous Administration of Two Doses of AFFITOPE® PD01A in Early Parkinson's Disease (NCT01568099) | Affiris AG | 2012-02-01 |
| Effect of Simvastatin Treatment on Vaso-occlusive Pain in Sickle Cell Disease (NCT01702246) | UCSF Benioff Children's Hospital Oakland | 2012-02-01 |
| Cognitive-Behavioral Physical Therapy (NCT01131611) | Vanderbilt University | 2012-02-01 |
| A Study Comparing PF-05089771 TS Tablet to PF-05089771 TS Oral Dispersion In The Fasted State And To PF-05089771 TS Tablet In The Fasted And Fed State (NCT01563497) | Pfizer | 2012-02-01 |
| Study of 18F-Fluoro-PEG6-IPQA (NCT01320059) | M.D. Anderson Cancer Center | 2012-02-01 |
| A Phase I Study of INC280 in Japanese Patients With Advanced Solid Tumors (NCT01546428) | Novartis Pharmaceuticals | 2012-02-01 |
| A Study of GL-ONC1, an Oncolytic Vaccinia Virus, in Patients With Advanced Peritoneal Carcinomatosis (NCT01443260) | Genelux GmbH | 2012-02-01 |
| Single Cohort 4-period Study to Assess Pharmacokinetics of Metformin Alone and in Combination With Ranolazine (NCT01546597) | Gilead Sciences | 2012-02-01 |
| Combining Curcumin With FOLFOX Chemotherapy in Patients With Inoperable Colorectal Cancer (NCT01490996) | University of Leicester | 2012-02-01 |
| Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects (NCT01590901) | Otsuka Beijing Research Institute | 2012-02-01 |
| A Phase I/II Open-Label Study of Ipilimumab and GM-CSF Administered to Unresectable Stage IIIC and Stage IV Melanoma Patients (NCT02009397) | University of Louisville | 2012-02-01 |
| Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer (NCT01674556) | Haukeland University Hospital | 2012-02-01 |
| Alpha-lipoic Acid in Patients at Risk for Paclitaxel Induced Neuropathy (NCT01313117) | Northwestern University | 2012-02-01 |
| MLN8237 in Head and Neck Cancer (NCT01540682) | Abramson Cancer Center at Penn Medicine | 2012-02-01 |
| A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast (NCT01561963) | Amgen | 2012-02-01 |
| An Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy Subjects (NCT01652859) | Taiwan Liposome Company | 2012-02-01 |
| The Effect of Liraglutide Adjunct to Insulin on Glucagon Response to Hypoglycaemia in Subjects With Type 1 Diabetes (NCT01536665) | Novo Nordisk A/S | 2012-02-01 |
| Safety and Immunogenicity of a New Inactivated Poliovirus Vaccine in Infants (NCT01709071) | Pauline Verdijk | 2012-02-01 |
| DFA-02 in Patients Undergoing Colorectal Surgery (NCT01496352) | Dr. Reddy's Laboratories Limited | 2012-02-01 |
| Safety, Tolerability, Pharmacokinetics and Efficacy of AZD1208 in Acute Myelogenous Leukemia (AML) Patients (NCT01489722) | AstraZeneca | 2012-02-01 |
| Safety, Tolerability, Pharmacokinetics, and Immunoregulatory Study of Urelumab (BMS-663513) in Subjects With Advanced and/or Metastatic Solid Tumors and Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (NCT01471210) | Bristol-Myers Squibb | 2012-02-01 |
| A Study of LY2484595 on the Electrical Activity of the Heart (NCT01537887) | Eli Lilly and Company | 2012-02-01 |
| A Study to Evaluate Safety and Tolerability of BMN 111 Administered to Healthy Adult Volunteers (NCT01590446) | BioMarin Pharmaceutical | 2012-02-01 |
| A Study of LY3009104 in Healthy Participants (NCT01536951) | Eli Lilly and Company | 2012-02-01 |
| A Phase Ib/II Study of BEZ235 and Trastuzumab in Patients With HER2-positive Breast Cancer Who Failed Prior to Trastuzumab (NCT01471847) | Novartis Pharmaceuticals | 2012-02-01 |
| CR Aim #2 - AT1 Receptor Blockade & ACE Inhibition Effect on Humoral Function (NCT01678794) | Mayo Clinic | 2012-02-01 |
| Effects of Age and Sex on the Pharmacokinetics of Apremilast in Healthy Adults (NCT01634191) | Amgen | 2012-02-01 |
| Distribution of Secukinumab (AIN457) Into Dermal Interstitial Fluid After a Single Subcutaneous Administration of 300 mg (NCT01539213) | Novartis Pharmaceuticals | 2012-02-01 |
| Coffee Interaction With the Antihypertensive Drug Felodipine (NCT02232269) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2012-02-01 |
| A Comparison of the Safety and Immunogenicity of Various Schedules of Dengue Vaccine in Healthy Adult Volunteers (NCT01542632) | Takeda | 2012-02-01 |
| An Extension Study of KRN23 in Adults With X-Linked Hypophosphatemia (NCT01571596) | Kyowa Kirin Co., Ltd. | 2012-02-01 |
| The Effects of Epinephrine in Endotoxemia in Normal Volunteers (NCT00753402) | Rutgers, The State University of New Jersey | 2012-02-01 |
| Study of NI-071 in Comparison With Remicade in Patients With Rheumatoid Arthritis (NCT01567358) | Nichi-Iko Pharmaceutical Co., Ltd. | 2012-02-01 |
| Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas (NCT01514201) | National Cancer Institute (NCI) | 2012-02-01 |
| An Open Label Study of the Effects of Eculizumab in CD59 Deficiency (NCT01579838) | Hadassah Medical Organization | 2012-02-01 |
| Bioavailability of 3 Different Formulations of BI 207127 in Healthy Male Volunteers (NCT01535638) | Boehringer Ingelheim | 2012-02-01 |
| The Role of Vasopressin Antagonism on Renal Sodium Handling (NCT03910231) | Brigham and Women's Hospital | 2012-02-01 |
| Feasibility of the Radio-Frequency Microstimulator System to Improve Arm Function Following Traumatic Brain Injury (NCT01488981) | The Alfred E. Mann Foundation for Scientific Research | 2012-02-01 |
| A Long Term Follow up Study for Patients Who Previously Took Part in the Phase I Study IMM-101-001 (NCT01559818) | Immodulon Therapeutics Ltd | 2012-02-01 |
| A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901 (NCT01526473) | H. Kim Lyerly | 2012-02-01 |
| Controlled Human Malaria Infection by Intradermal Injection of Plasmodium Falciparum Sporozoites in Tanzanian Adults (NCT01540903) | Sanaria Inc. | 2012-02-01 |
| A Study of the Effects of PEITC on Oral Cells With Mutant p53 (NCT01790204) | Georgetown University | 2012-02-01 |
| Evaluation of Oral Lipid Ingestion in Relation to Ovarian Androgen Secretion in Polycystic Ovary Syndrome (PCOS) (NCT01489319) | Indiana University | 2012-02-01 |
| Cognitive Effects of Vinpocetine in Healthy Adults and Patients With Epilepsy (NCT02011971) | Stanford University | 2012-02-01 |
| A Drug-Drug Interaction Study of Ambroxol and Levodropropizine (NCT01573663) | Hanmi Pharmaceutical Company Limited | 2012-02-01 |
| Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor (NCT01470794) | Tocagen Inc. | 2012-02-01 |
| Study to Test the Blood to See if a New Medicine is Likely to Provide Pain Relief Similar to a Product Already Sold in Stores (NCT01555476) | McNeil AB | 2012-02-01 |
| Novel 13C Carotenoids for Absorption and Metabolism Studies in Humans (NCT01692340) | Ohio State University Comprehensive Cancer Center | 2012-02-01 |
| Evaluation of Melatonin's Effect on Pain and Blood Loss After Cesarean Section (NCT01572805) | Qazvin University Of Medical Sciences | 2012-02-01 |
| Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients (NCT01521455) | Hanmi Pharmaceutical Company Limited | 2012-02-01 |
| Evaluate the Safety of Recombinant Human Papillomavirus Bivalent (Types 16 and 18) Vaccine (Yeast) in Healthy Females (NCT01548118) | Shanghai Zerun Biotechnology Co.,Ltd | 2012-02-01 |
| Biological Standardization of D. Glomerata, L. Perenne, S. Cereale and O. Europaea Pollen Extracts (NCT01567319) | Roxall Medicina España S.A | 2012-02-01 |
| GW824575 First Time in Human (NCT01551771) | GlaxoSmithKline | 2012-02-01 |
| Food Effect on Pharmacokinetics of YH4808 in Healthy Male Subjects (NCT01520012) | Yuhan Corporation | 2012-02-01 |
| Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors (NCT01538095) | National Cancer Institute (NCI) | 2012-02-01 |
| Phase I Safety Trial of Streptococcus Pneumoniae Whole Cell Vaccine (SPWCV) + Alum in Healthy Adults (NCT01537185) | PATH Vaccine Solutions | 2012-02-01 |
| to Evaluate the Pharmacokinetics(Cmax, Auc) of CJ Imatinib Mesylate Tablet 200mg x 1 Compared With Gleevec Film-coated Tablet 100mg x 2 in Healthy Male Volunteers (NCT01926548) | HK inno.N Corporation | 2012-02-01 |
| A Study of Trastuzumab Emtansine in Patients With HER2-Positive Metastatic Breast Cancer and Normal or Reduced Hepatic Function (NCT01513083) | Hoffmann-La Roche | 2012-02-01 |
| Intra-dermal Injections of DLX105 Into Lesional Skin in Patients With Mild-to-moderate Psoriasis Vulgaris (NCT01595997) | Delenex Therapeutics AG | 2012-02-01 |
| Monoaminergic Modulation of Motor Function in Subacute Incomplete Spinal Cord Injury (SCI) (NCT01753882) | Shirley Ryan AbilityLab | 2012-02-01 |
| A Clinical Study to Evaluate Safety and Immunologic Response of COMBIG-DC, in Patients With Metastatic Kidney Cancer (NCT01525017) | Mendus | 2012-02-01 |
| Dose Escalation Trial of a Plague Vaccine, Flagellin/F1/V, in Healthy Adult Volunteers (NCT01381744) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-02-01 |
| A Phase I, First-in-man Study of OTX008 Given Subcutaneously as a Single Agent to Patients With Advanced Solid Tumors (NCT01724320) | Oncoethix GmbH, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2012-02-01 |
| Safety Study of Recombinant Listeria Monocytogenes(Lm)Based Vaccine Virus Vaccine to Treat Oropharyngeal Cancer (NCT01598792) | University of Liverpool | 2012-02-01 |
| Early Rehabilitation in Critically Ill Children Pilot Study (NCT01531816) | McMaster University | 2012-02-01 |
| Propranolol for Diabetic Retinopathy (NCT01535495) | University of Wisconsin, Madison | 2012-02-01 |
| Rocking Motion: Physiologic Effect on the Surgical Stress Response (NCT01200316) | M.D. Anderson Cancer Center | 2012-02-01 |
| Study of Dalotuzumab Alone and With Ridaforolimus in Pediatric Participants With Advanced Solid Tumors (MK-8669-062 AM1) (NCT01431547) | Merck Sharp & Dohme LLC | 2012-02-01 |
| A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma (NCT01537744) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-02-01 |
| Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158 (NCT01533961) | Drugs for Neglected Diseases | 2012-02-01 |
| Study of Ketamine as an Antidepressant in Major Depressive Disorder (NCT01573741) | Shi Jinyun | 2012-02-01 |
| Topical Resiquimod for the Treatment of Early Stage Cutaneous T Cell Lymphoma (CTCL) (NCT01676831) | Abramson Cancer Center at Penn Medicine | 2012-02-01 |
| A Healthy Volunteer Study to Investigate the Blood Concentrations, the Effect on Blood Clotting and the Safety of Multiple Doses of DPOC-4088 Tablets in Different Doses. (NCT01647620) | Diakron Pharmaceuticals | 2012-02-01 |
| Combined Use of Oxytocin and Misoprostol Versus Oxytocin Infusion and Misoprostol Alone to Reduce Blood Loss at Cesarean Section (NCT01571323) | Qazvin University Of Medical Sciences | 2012-02-01 |
| Bioavailability of ASKP1240 in Healthy Subjects After Intravenous and Subcutaneous Administration of ASKP1240 (NCT01582399) | Astellas Pharma Global Development, Inc. | 2012-02-01 |
| Provide Initial Evidence of Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy to Support the Pivotal CT-P10 Therapeutic Equivalence Trial (NCT01534949) | Celltrion | 2012-02-01 |